Breeze Acquisition Corp. II Announces Pricing of $125,000,000 Initial Public Offering
Breeze Acquisition Corp. II (Nasdaq:BREZU/BREZ) priced its initial public offering of 12,500,000 units at $10.00 per unit, for gross proceeds of $125 million.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Breeze Acquisition Corp. II (Nasdaq:BREZU/BREZ) priced its initial public offering of 12,500,000 units at $10.00 per unit, for gross proceeds of $125 million. Units are expected to begin trading on May 13, 2026.
Each unit includes one ordinary share and one right, with each right converting into one-fifth of a share after a business combination. Underwriters hold a 45-day option for up to 1,875,000 additional units.
Positive
- Initial public offering of 12,500,000 units at $10.00, totaling $125 million
- Underwriters granted 45-day option to purchase up to 1,875,000 additional units
Negative
- None.
Key Figures
- IPO size
- $125,000,000
- Initial public offering of Breeze Acquisition Corp. II
- Units offered
- 12,500,000 units
- Base IPO size
- Unit price
- $10.00 per unit
- IPO pricing to the public
- Right conversion
- 1/5 of one share
- Each right per unit upon business combination
- Over-allotment option
- 1,875,000 units
- Underwriters’ 45-day option to cover over-allotments
- Over-allotment period
- 45 days
- Duration of underwriters’ option
- Nasdaq trading date
- May 13, 2026
- Expected commencement of trading for units under BREZU
- SEC effectiveness date
- May 12, 2026
- Registration statement declared effective by SEC
Key Terms
unit financial
over-allotments financial
book-running managers financial
prospectus regulatory
registration statement regulatory
Securities and Exchange Commission regulatory
Nasdaq Global Market regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
Irving, TX, May 12, 2026 (GLOBE NEWSWIRE) -- Breeze Acquisition Corp. II (the “Company”) announced today that it priced its initial public offering of 12,500,000 units at a price to the public of
Each unit consists of one ordinary share and one right. Each right entitles the holder to receive one-fifth (1/5) of one ordinary share upon the consummation of an initial business combination. Once the securities comprising the units begin separate trading, the ordinary shares and rights are expected to be traded on the Nasdaq Global Market under the symbols “BREZ” and “BREZR,” respectively.
IB Capital LLC and I-Bankers Securities, Inc. are acting as book-running managers of the offering. The underwriters have been granted a 45-day option to purchase up to an additional 1,875,000 units offered by the Company to cover over-allotments, if any. The offering is expected to close on or about May 14, 2026, subject to customary closing conditions.
The offering is being made only by means of a prospectus. When available, copies of the prospectus related to this offering may be obtained from IB Capital LLC at 51 Kings Court St; PH, San Juan, PR 00911.
A registration statement relating to the securities was declared effective by the Securities and Exchange Commission (“SEC”) on May 12, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Breeze Acquisition Corp. II
Breeze Acquisition Corp. II is a blank check company incorporated in the Cayman Islands for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses or entities. The Company intends to focus its initial search on target businesses with global operations and differentiated technology or capabilities, particularly in healthcare, biotechnology, advanced manufacturing, robotics, artificial intelligence, and related sectors. The net proceeds of the offering will be used to fund such business combination.
Forward-Looking Statements
This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements, including with respect to the closing of the initial public offering and the anticipated use of the net proceeds thereof, are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements, including those set forth in the risk factors section of the prospectus used in connection with the Company’s initial public offering filed with the SEC, copies of which are available on the SEC’s website, at www.sec.gov. No assurance can be given the offering discussed above will be completed on the terms described, or at all, or the net proceeds of the offering will be used as indicated. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based, except as required by law.
Contact:
J. Douglas Ramsey
Breeze Acquisition Corp. II
955 W. John Carpenter Fwy
Suite 100-929
Irving, TX 75039
(888) 273-9001
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.